Download MendeleyDesign, synthesis, and bioactivity evaluation of macrocyclic benzo[b]pyrido[4,3-e][1,4]oxazine derivatives as novel Pim-1 kinase inhibitors.
Xu, J., Shen, C., Xie, Y., Qiu, B., Ren, X., Zhou, Y., Li, G., Zheng, G., Huang, N.(2022) Bioorg Med Chem Lett 72: 128874-128874
- PubMed: 35779826
- DOI: https://doi.org/10.1016/j.bmcl.2022.128874
- Primary Citation of Related Structures:
7XSV - PubMed Abstract:
Pim-1 kinase is a serine/threonine kinase which is vital in many tumors. The Pim-1 inhibitor 10-DEBC and its derivatives discovered in our previous work were modified through macrocyclization strategy. A series of benzo[b]pyridine[4,3-e][1,4]oxazine macrocyclic compounds were designed, synthesized, and evaluated as novel Pim-1 kinase inhibitors. Among these compounds, compound H5 exhibited the highest activity with an IC 50 value of 35 nM. In addition, the crystal complex structure of Pim-1 kinase bound with compound H3 was determined, and the structure-activity relationship of these macrocyclic compounds was analyzed, which provides the structural basis of further optimization of novel macrocyclic Pim-1 kinase inhibitors..
Organizational Affiliation:
College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: jwxu3@buct.edu.cn.
